BIOGEN INC. (BIIB) Shareholders’ equity 2016–2025
BIOGEN INC. (BIIB) shareholders’ equity at each fiscal year-end, per SEC filings.
$18.3BFY2025 · since FY2016: $12.1B → $18.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $18.3B | +9.2% |
| FY2024 | $16.7B | +13.0% |
| FY2023 | $14.8B | +10.5% |
| FY2022 | $13.4B | +23.0% |
| FY2021 | $10.9B | +1.8% |
| FY2020 | $10.7B | -19.8% |
| FY2019 | $13.3B | +2.3% |
| FY2018 | $13.0B | +3.4% |
| FY2017 | $12.6B | +3.9% |
| FY2016 | $12.1B | — |
Source: SEC XBRL filings · For reference only · Not investment advice